Metabolic correction of experimental diabetic retinopathy
Introduction. Diabetic retinopathy (DR) is diagnosed in 50% of the total number of patients suffering from type 1 diabetes mellitus with diabetes duration of over 10 years and in 75-90% of patients with diabetes duration over 15 years. Purpose. To ground the possibility of using arginine for correct...
Saved in:
Main Authors: | I.V. Savitskyi (Author), V.V. Semenko (Author), V.M. Serdiuk (Author) |
---|---|
Format: | Book |
Published: |
Ukrainian Society of Ophthalmologists,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mathematical substantiation of the method for assessing the risk of progression of diabetic retinopathy with serum leptin determination in patients with metabolic syndrome and diabetes mellitus
by: V. N. Serdiuk, et al.
Published: (2018) -
Prognostic biomarkers of non-proliferative diabetic retinopathy progression in type 2 diabetes mellitus
by: S. Iu. Mogilevskii, et al.
Published: (2024) -
Activity of plasminogen activator inhibitor-1 in blood of patients with metabolic syndrome depending on a stage of diabetic retinopathy
by: Serdiuk V. N., et al.
Published: (2018) -
Changes in endothelial nitric oxide synthase activity over time after induction of experimental diabetic retinopathy
by: Ya.V. Sirman, et al.
Published: (2020) -
A study on the lipid peroxidation status and the antioxidant system in rats at experimental diabetic retinopathy
by: Volodymyr Volodymyrovych Semenko, et al.
Published: (2017)